GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, APP, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD2, ESR1, FABP3, FABP4, FUT7, HSD11B1, HSD17B1, HSD17B2, MET, MIF, PDE3A, PPARA |
10.1935 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, TYR |
9.37067 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, APP, AXL, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, FABP3, HSD17B2, IGF1R, MMP2, MMP9, OPRK1, OPRM1, PDE3A, PDE3B, PPARA, SRC, TYR |
9.10123 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX5, AOX1, APP, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FABP3, FUT7, MIF, PDE10A, PDE3A, PDE3B, PIM1, PPARA, TYR, XDH |
8.93711 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, ESR1, HSD11B1, HSD17B1, HSD17B2 |
8.32139 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, ALPL, APP, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, FABP3, FABP4, FLT3, HSD17B2, IGF1R, KDR, MMP2, OPRD1, OPRK1, OPRM1, PDE3A, PDE3B, PPARA, SRC, TYR |
8.32139 |
[BP] GO:0042221 |
response to chemical
|
AKR1B1, ALPL, APP, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, FABP3, FABP4, FLT3, HSD17B2, HTR2A, IGF1R, KDR, MMP2, MMP9, OPRD1, OPRK1, OPRM1, PDE3A, PDE3B, PPARA, SRC, TYR |
7.62619 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, APP, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, FLT3, OPRK1, OPRM1, PDE3A, SRC, TYR |
7.43763 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, AKR1B1, APP, AURKB, AXL, CA12, CA2, CA7, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, ESR1, FABP3, FABP4, FLT3, HCAR2, HSD11B1, HSD17B1, HSD17B2, HTR1A, HTR2A, HTR7, KDR, MET, MIF, OPRD1, OPRK1, OPRM1, PDE3A, PPARA, SRC, XDH |
7.17612 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, ALPL, APP, CA2, CA9, CSNK2A1, CYP1A2, DRD1, ESR1, ESRRA, FABP3, FLT3, IGF1R, MMP2, OPRK1, OPRM1, PDE3A, PDE3B, PPARA, SRC |
7.15208 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, CYP19A1, CYP1A1, CYP1B1, DRD2, ESR1, HCAR2, HSD11B1, HSD17B1, HSD17B2, HTR1A, HTR2A, OPRK1 |
6.80748 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.80748 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, AKR1B1, APP, CDC25B, CSNK2A1, CYP1B1, DRD2, ESR1, ESRRA, FABP3, FLT3, HTR1A, HTR2A, IGF1R, KDR, MIF, MMP12, MMP2, MMP9, OPRM1, PIM1, SRC, XDH |
6.49836 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, AKR1B1, APP, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, FLT3, HCAR2, HTR2A, KDR, MET, MIF, MMP12, MMP9, OPRK1, OPRM1, PTPN1, SRC, XDH |
6.45372 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, AKR1B1, APP, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, FLT3, HCAR2, HTR2A, KDR, MET, MIF, MMP12, MMP9, OPRK1, OPRM1, PTPN1, SRC, XDH |
6.43546 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, AKR1B1, APP, AURKB, AXL, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FLT3, HCAR2, HTR1A, HTR2A, IGF1R, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, OPRD1, OPRK1, OPRM1, PDE3A, PIM1, PPARA, PTPN1, SRC, XDH |
6.29847 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APP, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, HSD11B1, HSD17B1, HSD17B2, HTR1A, IGF1R, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, PDE10A, PDE3A, PDE3B, PIM1, PPARA, PTPN1, SENP6, SRC, TYR, XDH |
5.98992 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, MIF |
5.98992 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, HSD17B2, OPRK1, OPRM1, SRC, TYR |
5.87428 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7, CA9 |
5.81616 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX5, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD2, FABP3, FABP4, FUT7, MET, MIF, PDE3A, PPARA |
5.81616 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, MIF |
5.81616 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, APP, AXL, CYP19A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRB, FABP4, HSD17B2, HTR1A, HTR2A, HTR7, IGF1R, MET, MMP1, MMP12, MMP2, MMP9, OPRD1, OPRK1, OPRM1, PDE3A, PIM1, PPARA, SRC, TYR |
5.75084 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AOX1, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, FABP3, FABP4, FUT7, MMP1, MMP12, MMP2, MMP9, PDE10A, PDE3A, PDE3B, SRC, XDH |
5.72551 |
[BP] GO:0009698 |
phenylpropanoid metabolic process
|
CYP1A1, CYP2A13, CYP2A6, CYP2D6 |
5.61794 |
[BP] GO:0009804 |
coumarin metabolic process
|
CYP1A1, CYP2A13, CYP2A6, CYP2D6 |
5.61794 |
[BP] GO:0007193 |
None
|
ADORA1, DRD2, HTR1A, HTR7, OPRD1, OPRK1, OPRM1 |
5.42417 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, AKR1B1, APP, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, FLT3, HCAR2, HTR1A, HTR2A, IGF1R, KDR, MET, MIF, MMP12, MMP9, OPRK1, OPRM1, PDE10A, PDE3B, PTPN1, SRC, XDH |
5.42417 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
5.41425 |
[BP] GO:0038003 |
None
|
OPRD1, OPRK1, OPRM1, SIGMAR1 |
5.38972 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, AKR1B1, APP, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, FLT3, HCAR2, HTR1A, HTR2A, IGF1R, KDR, MET, MIF, MMP12, MMP9, OPRK1, OPRM1, PDE10A, PDE3B, PTPN1, SRC, XDH |
5.36069 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, AKR1B1, APP, AURKB, AXL, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, HCAR2, HTR1A, HTR2A, IGF1R, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, OPRD1, OPRK1, OPRM1, PDE3A, PIM1, PPARA, PTPN1, SRC, XDH |
5.36069 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALPL, APP, AXL, CYP1A1, CYP1A2, CYP1B1, DRD1, ESR1, FABP4, FLT3, IGF1R, KDR, MMP2, MMP9, OPRD1, OPRK1, OPRM1, PDE3A, PDE3B, SRC |
5.3193 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD11B1, HSD17B1, HSD17B2 |
5.2754 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALPL, APP, AXL, CYP1A1, CYP1B1, DRD1, ESR1, FABP4, FLT3, IGF1R, KDR, MMP2, OPRD1, OPRK1, OPRM1, PDE3A, PDE3B, SRC |
5.24564 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, AKR1B1, APP, AURKB, AXL, CSNK2A1, CYP1B1, DRD2, ESR1, FLT3, HTR2A, IGF1R, KDR, MET, MIF, MMP9, OPRK1, OPRM1, PDE10A, PDE3B, PTPN1, SRC, XDH |
5.24123 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APP, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSD17B2, HTR1A, IGF1R, KDR, MET, MIF, MMP1, MMP2, PDE10A, PDE3A, PDE3B, PIM1, PPARA, PTPN1, SENP6, SRC, TYR, XDH |
5.2206 |
[BP] GO:0007200 |
None
|
DRD1, DRD2, ESR1, HTR2A, OPRD1, OPRK1, OPRM1 |
5.1674 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, APP, CDC25B, DRD1, DRD2, ESRRB, FABP3, FLT3, HTR2A, KDR, MIF, MMP9, OPRD1, OPRK1, OPRM1, PTPN1, SRC, XDH |
5.1674 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, APP, CDC25B, DRD1, DRD2, ESRRB, FABP3, FLT3, HTR2A, KDR, MIF, MMP9, OPRD1, OPRK1, OPRM1, PTPN1, SRC, XDH |
5.1674 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, ALPL, APP, AURKB, AXL, CA2, CA9, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, ESRRB, FABP4, FLT3, FUT7, HSD11B1, HSD17B2, HTR2A, KDR, MET, MIF, MMP2, MMP9, PDE3A, PDE3B, PIM1, PPARA, SIGMAR1, SRC, TYR |
5.13241 |
[BP] GO:0030534 |
None
|
APP, DRD1, DRD2, HTR2A, OPRD1, OPRK1, OPRM1, PPARA |
5.06741 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6 |
5.01792 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APP, DRD1, DRD2, FABP3, FLT3, IGF1R, MMP2, OPRK1, OPRM1, PDE3A, PDE3B, PPARA, SRC, TYR |
4.99299 |
[BP] GO:0007186 |
G-protein coupled receptor signaling pathway
|
ADORA1, ADORA3, APP, CA2, DRD1, DRD2, ESR1, HCAR2, HTR1A, HTR2A, HTR7, OPRD1, OPRK1, OPRM1, PDE10A, PDE3A, PDE3B, SIGMAR1, SRC |
4.94561 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, ALPL, CA2, CA9, CSNK2A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, OPRK1, PDE3B, PPARA, SRC |
4.91428 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, HSD11B1, HSD17B1, HSD17B2, TYR, XDH |
4.90468 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, APP, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, HCAR2, HTR1A, HTR2A, IGF1R, KDR, MET, MIF, MMP12, MMP9, OPRD1, OPRK1, OPRM1, PPARA, PTPN1, SRC |
4.88031 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, APP, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, FABP4, KDR, MMP9, SRC |
4.85246 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, MIF |
4.78674 |
[BP] GO:0007188 |
None
|
ADORA1, DRD1, DRD2, HTR1A, HTR7, OPRD1, OPRK1, OPRM1 |
4.77087 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FABP3, MIF, PPARA |
4.75971 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, FLT3, HCAR2, IGF1R, KDR, MET, MIF, MMP9, PDE3A, PIM1, PPARA, PTPN1, SIGMAR1, SRC, XDH |
4.75568 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, AURKB, CA2, CA7, DRD1, DRD2, HCAR2, HTR2A, KDR, MIF, OPRK1, SRC |
4.75568 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, AKR1B1, APP, AXL, CA1, CA2, CSNK2A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, FLT3, HCAR2, HTR1A, HTR2A, HTR7, IGF1R, KDR, MET, MIF, MMP2, MMP9, OPRD1, OPRK1, OPRM1, PDE10A, PDE3A, PDE3B, PIM1, PPARA, PTPN1, SIGMAR1, SRC |
4.67545 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, APP, CDC25B, DRD1, DRD2, ESRRB, FABP4, FLT3, HTR2A, IGF1R, KDR, MIF, MMP9, OPRD1, OPRK1, OPRM1, PPARA, PTPN1, SRC, XDH |
4.67545 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, APP, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, CYP2D6, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, HTR2A, IGF1R, KDR, MET, MIF, MMP12, MMP9, OPRD1, OPRK1, OPRM1, PDE3A, PDE3B, PIM1, PPARA, PTPN1, SRC, XDH |
4.66634 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
4.65506 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APP, DRD1, DRD2, FABP3, FLT3, IGF1R, MMP2, OPRK1, OPRM1, PDE3A, PDE3B, PPARA, SRC, TYR |
4.64751 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, FLT3, HCAR2, IGF1R, KDR, MET, MIF, MMP9, PDE3A, PIM1, PTPN1, SIGMAR1, SRC, XDH |
4.62127 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, AKR1B1, ALPL, APP, AURKB, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, FABP3, FABP4, FLT3, HSD17B2, HTR1A, HTR2A, IGF1R, KDR, MIF, MMP12, MMP2, MMP9, OPRD1, OPRK1, OPRM1, PDE3A, PDE3B, PPARA, PTPN1, SRC, TYR |
4.59141 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, AXL, CYP1A1, CYP1B1, DRD1, DRD2, KDR, OPRD1, OPRK1, SRC |
4.57436 |
[BP] GO:0043269 |
regulation of ion transport
|
ADORA1, APP, CA2, CA7, DRD1, DRD2, HTR1A, HTR2A, MIF, MMP9, OPRD1, OPRK1, OPRM1 |
4.53458 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, AKR1B1, APP, AXL, CYP1B1, DRD2, FLT3, HTR2A, KDR, MET, MIF, OPRK1, OPRM1, PTPN1, SRC, XDH |
4.49309 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, APP, DRD2, FLT3, HTR2A, KDR, MIF, OPRK1, OPRM1, PTPN1, SRC, XDH |
4.47382 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, AXL, CA9, CYP1A1, CYP1B1, DRD1, DRD2, FABP3, HTR2A, KDR, OPRK1, OPRM1, PDE3A, SRC |
4.4435 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, APP, CDC25B, DRD2, ESRRB, FLT3, HTR2A, KDR, MIF, MMP9, OPRD1, OPRK1, OPRM1, PTPN1, SRC, XDH |
4.42944 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, APP, CDC25B, DRD1, DRD2, ESRRB, FABP3, FABP4, FLT3, HTR2A, IGF1R, KDR, MIF, MMP9, OPRD1, OPRK1, OPRM1, PPARA, PTPN1, SRC, XDH |
4.40748 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALPL, APP, AURKB, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD1, ESR1, FABP4, FLT3, IGF1R, KDR, MIF, MMP2, MMP9, OPRD1, OPRK1, OPRM1, PDE3A, PDE3B, PTPN1, SRC |
4.37244 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, DRD1, DRD2, ESR1, ESR2, HTR2A, IGF1R, MET, MIF, MMP12, MMP9, OPRK1, OPRM1, PDE3B, PTPN1, SRC, XDH |
4.37141 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, APP, AURKB, CA2, CYP1A1, DRD1, DRD2, HTR2A, MMP2, OPRD1, OPRK1, OPRM1, PPARA, SRC, TYR |
4.37141 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, APP, CDC25B, DRD1, DRD2, ESRRB, FABP3, FABP4, FLT3, HTR2A, IGF1R, KDR, MIF, MMP9, OPRD1, OPRK1, OPRM1, PPARA, PTPN1, SRC, XDH |
4.37141 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, DRD1, DRD2, ESR1, ESR2, HTR2A, IGF1R, MET, MIF, MMP12, MMP9, OPRK1, OPRM1, PDE3B, PTPN1, SRC, XDH |
4.36076 |
[BP] GO:0007187 |
None
|
ADORA1, DRD1, DRD2, HTR1A, HTR7, OPRD1, OPRK1, OPRM1 |
4.36076 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, CDC25B, CSNK2A1, DRD2, ESR1, FLT3, HTR1A, HTR2A, IGF1R, KDR, MIF, MMP12, MMP2, MMP9, PIM1 |
4.31203 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, APP, AURKB, CSNK2A1, CYP1B1, CYP2D6, DRD2, ESR1, FABP4, IGF1R, MET, MMP9, OPRM1, PIM1, PPARA, PTPN1, SRC |
4.25026 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, AKR1B1, APP, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, CYP2D6, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, HCAR2, HTR2A, IGF1R, KDR, MET, MIF, MMP12, MMP9, OPRD1, OPRK1, OPRM1, PDE3A, PDE3B, PIM1, PPARA, PTPN1, SRC, XDH |
4.20876 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, APP, CYP1A1, CYP1B1, DRD1, ESR1, FLT3, OPRM1, PDE3A, SRC |
4.20876 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AXL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, ESR1, ESRRA, ESRRB, FLT3, HSD11B1, HSD17B2, KDR, PPARA, SRC, TYR |
4.15872 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, FLT3, HCAR2, IGF1R, KDR, MIF, MMP9, PDE3A, PIM1, PTPN1, SIGMAR1, SRC, XDH |
4.08435 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, AKR1B1, APP, AXL, CSNK2A1, CYP1B1, DRD2, FLT3, HTR2A, KDR, MET, MIF, MMP12, MMP9, OPRK1, OPRM1, PTPN1, SRC, XDH |
4.04917 |
[BP] GO:0048511 |
rhythmic process
|
AXL, CSNK2A1, DRD2, ESR1, HTR7, OPRK1, OPRM1, PPARA, SRC |
3.99787 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, APP, AXL, CA2, CA7, CYP19A1, DRD1, DRD2, HCAR2, HTR1A, HTR2A, MIF, MMP12, MMP9, OPRD1, OPRK1, OPRM1, PPARA, PTPN1, SRC |
3.99499 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, CA2, CA7, DRD1, DRD2, HTR2A, KDR, SRC |
3.9825 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, APP, CDC25B, DRD2, FLT3, HTR2A, KDR, MIF, MMP9, OPRD1, OPRK1, OPRM1, PTPN1, SRC, XDH |
3.9825 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, APP, CDC25B, DRD1, DRD2, FABP4, FLT3, HTR2A, IGF1R, KDR, MIF, MMP9, OPRD1, OPRK1, OPRM1, PTPN1, SRC, XDH |
3.97583 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, IGF1R, KDR, MET, MIF, MMP9, PDE3A, PIM1, PPARA, PTPN1, SRC |
3.96128 |
[BP] GO:0048148 |
None
|
DRD1, DRD2, HTR2A, OPRK1 |
3.96086 |
[BP] GO:0072523 |
None
|
AOX1, PDE10A, PDE3A, PDE3B, XDH |
3.86921 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, APP, DRD2, FLT3, HTR2A, IGF1R, KDR, MIF, OPRK1, OPRM1, PTPN1, SRC, XDH |
3.85505 |
[BP] GO:0007631 |
None
|
APP, DRD1, DRD2, OPRD1, OPRK1, OPRM1 |
3.81537 |
[BP] GO:0003018 |
None
|
ADORA1, DRD1, HTR1A, HTR2A, HTR7, PDE3A, SRC |
3.76446 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, IGF1R, KDR, MET, MIF, MMP9, PDE3A, PIM1, PTPN1, SRC |
3.70804 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6 |
3.6944 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.66736 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APP, AURKB, AXL, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, HSD11B1, HSD17B1, HSD17B2, IGF1R, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, PDE10A, PDE3A, PDE3B, PIM1, PPARA, PTPN1, SENP6, SRC, TYR, XDH |
3.66486 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, APP, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, HTR1A, TYR |
3.64965 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APP, AXL, CYP1B1, DRD1, ESR1, IGF1R, MMP2, MMP9, OPRK1, PDE3A, PDE3B, SRC |
3.64875 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD2, FABP3, PPARA |
3.62204 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APP, AURKB, AXL, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, HSD11B1, HSD17B1, HSD17B2, HTR1A, IGF1R, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, PDE10A, PDE3A, PDE3B, PIM1, PPARA, PTPN1, SENP6, SRC, TYR, XDH |
3.61185 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, APP, CYP19A1, CYP1B1, DRD1, DRD2, IGF1R, KDR, MET, MIF, MMP9, OPRK1, SRC |
3.61025 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, APP, AURKB, CDC25B, CSNK2A1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, FLT3, HTR2A, IGF1R, KDR, MET, MIF, MMP12, MMP9, OPRD1, OPRK1, OPRM1, PPARA, PTPN1, SRC, XDH |
3.60081 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, AOX1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, DRD1, DRD2 |
3.59639 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, AKR1B1, APP, AXL, CSNK2A1, CYP1B1, DRD2, ESRRA, FABP4, FLT3, HTR2A, KDR, MET, MIF, MMP12, MMP2, MMP9, OPRK1, OPRM1, PTPN1, SRC, XDH |
3.57853 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2D6, PDE3A |
3.56442 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, APP, CYP19A1, CYP1B1, DRD1, DRD2, IGF1R, KDR, MET, MIF, MMP9, SRC |
3.55777 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD11B1, HSD17B1, HSD17B2 |
3.50292 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, ALPL, APP, AXL, CDC25B, CYP19A1, CYP1A1, DRD1, ESR1, ESRRB, HSD17B2, MMP2, MMP9, OPRK1, OPRM1, PDE3A, SRC |
3.48735 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PIM1, PPARA, SRC |
3.4768 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, AKR1B1, APP, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, ESRRA, FABP4, FLT3, HTR2A, IGF1R, KDR, MET, MIF, MMP12, MMP2, MMP9, OPRK1, OPRM1, PDE10A, PDE3B, PPARA, PTPN1, SRC, XDH |
3.42918 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, ALPL, APP, AXL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, ESRRB, FLT3, HSD11B1, HSD17B2, KDR, MMP9, PIM1, PPARA, SIGMAR1, SRC, TYR |
3.41834 |
[BP] GO:0050805 |
negative regulation of synaptic transmission
|
ACHE, ADORA1, DRD1, DRD2, HTR2A |
3.41656 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, AKR1B10, CSNK2A1, DRD1, DRD2, HTR1A |
3.37848 |
[BP] GO:1903530 |
regulation of secretion by cell
|
ACHE, ADORA1, CYP19A1, DRD2, HCAR2, HTR1A, HTR2A, MIF, MMP12, OPRK1, OPRM1, SRC |
3.366 |
[BP] GO:1901575 |
None
|
ACHE, ADORA1, AKR1B10, AOX1, AURKB, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, FABP3, FABP4, FUT7, PDE10A, PDE3A, PDE3B, XDH |
3.35796 |
[BP] GO:0048871 |
multicellular organismal homeostasis
|
ADORA1, AKR1B1, DRD1, DRD2, HTR2A, MET |
3.35796 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, APP, AURKB, CDC25B, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FLT3, HTR2A, IGF1R, KDR, MET, MIF, MMP12, MMP9, OPRD1, OPRK1, OPRM1, PPARA, PTPN1, SRC, XDH |
3.34604 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, APP, AURKB, CDC25B, CSNK2A1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, FLT3, HTR2A, IGF1R, KDR, MET, MIF, MMP12, MMP9, OPRD1, OPRK1, OPRM1, PPARA, PTPN1, SRC, XDH |
3.30841 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, APP, CA2, CA7, DRD1, DRD2 |
3.30581 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, APP, CYP19A1, CYP1B1, DRD1, DRD2, IGF1R, KDR, MET, MIF, MMP9, SRC |
3.30534 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, APP, AXL, CA2, CYP1B1, DRD2, ESR1, ESRRA, ESRRB, HCAR2, HTR2A, KDR, MET, MIF, MMP12, MMP9, OPRD1, OPRK1, OPRM1, PDE3A, PDE3B, PIM1, SRC, XDH |
3.30402 |
[BP] GO:0001659 |
None
|
ADORA1, DRD1, DRD2, HTR2A |
3.30402 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, CYP1A1, FABP3, FLT3, HCAR2, HTR2A, PDE3B, PPARA, SRC |
3.28758 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, APP, AURKB, CDC25B, CSNK2A1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FLT3, HTR2A, IGF1R, KDR, MET, MIF, MMP12, MMP9, OPRD1, OPRK1, OPRM1, PPARA, PTPN1, SRC, XDH |
3.26677 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, CA2, CA7, DRD2 |
3.25654 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
APP, DRD2, HTR2A, KDR, MIF, OPRM1, PTPN1, SRC |
3.25654 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2D6, PDE3A |
3.24549 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.22946 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, FLT3, IGF1R, KDR, PIM1, SRC |
3.21533 |
[BP] GO:0070374 |
positive regulation of ERK1 and ERK2 cascade
|
APP, DRD2, HTR2A, KDR, MIF, OPRM1, SRC |
3.20338 |
[BP] GO:0032787 |
None
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FABP3, MIF, PPARA |
3.20238 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALPL, APP, AURKB, AXL, CDC25B, CSNK2A1, DRD1, DRD2, FLT3, IGF1R, KDR, MET, PDE10A, PDE3A, PDE3B, PIM1, PTPN1, SRC, XDH |
3.18348 |
[BP] GO:0051930 |
None
|
ADORA1, OPRD1, OPRK1, OPRM1 |
3.17282 |
[BP] GO:0051931 |
None
|
ADORA1, OPRD1, OPRK1, OPRM1 |
3.17282 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, SRC |
3.17008 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, IGF1R, KDR, MIF, MMP9, PDE3A, PIM1, PTPN1, SRC |
3.16979 |
[BP] GO:0051047 |
None
|
ACHE, ADORA1, CYP19A1, DRD2, HCAR2, MIF, MMP12, OPRK1, SRC |
3.14677 |
[BP] GO:0051952 |
None
|
ADORA1, DRD1, DRD2, HTR2A, OPRK1 |
3.12738 |
[BP] GO:0003013 |
None
|
ADORA1, DRD1, HTR1A, HTR2A, HTR7, PDE3A, SRC |
3.12422 |
[BP] GO:0051046 |
None
|
ACHE, ADORA1, CYP19A1, DRD2, HCAR2, HTR1A, HTR2A, MIF, MMP12, OPRK1, OPRM1, SRC |
3.12422 |
[BP] GO:0018958 |
None
|
AKR1B1, DRD1, DRD2, HTR1A, TYR |
3.08481 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, APP, DRD1, IGF1R, MMP2, OPRM1, PDE3A, PDE3B, SRC |
3.05372 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, APP, CA2, CA7, DRD1, DRD2, HTR2A |
3.01672 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, APP, CA2, CA7, DRD1, DRD2, HTR2A |
3.01672 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, APP, CYP19A1, CYP1B1, DRD1, DRD2, IGF1R, KDR, MET, MIF, MMP9, SRC |
2.997 |
[BP] GO:0097756 |
None
|
ADORA1, HTR1A, HTR2A, HTR7 |
2.97254 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
DRD2, ESR1, IGF1R, MET, MIF, MMP9, PDE3B, PTPN1, SRC, XDH |
2.96727 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPL, AOX1, APP, AURKB, AXL, CDC25B, CSNK2A1, CYP1A1, CYP1A2, CYP2D6, DRD1, DRD2, ESR1, FLT3, FUT7, HTR1A, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PDE10A, PDE3A, PDE3B, PIM1, PPARA, PTPN1, SENP6, SRC, TYR, XDH |
2.95393 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, AKR1B1, APP, AXL, CA12, CA2, CA7, DRD1, DRD2, ESR1, FABP3, FABP4, FLT3, HTR2A, MET, SRC |
2.94017 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALPL, APP, AURKB, AXL, CDC25B, CSNK2A1, DRD1, DRD2, FLT3, IGF1R, KDR, MET, PDE10A, PDE3A, PDE3B, PIM1, PTPN1, SRC, XDH |
2.94017 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.92761 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, APP, CDC25B, DRD2, FLT3, HTR2A, KDR, MIF, MMP9, OPRD1, OPRK1, OPRM1, PTPN1, SRC, XDH |
2.91853 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
APP, AXL, CA2, CYP1B1, DRD2, ESRRB, HCAR2, HTR2A, KDR, MET, MIF, MMP12, MMP9, OPRM1, PDE3A, PIM1, SRC |
2.91315 |
[BP] GO:0044248 |
cellular catabolic process
|
ACHE, AKR1B10, AOX1, AURKB, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, FABP3, FABP4, PDE10A, PDE3A, PDE3B, SRC, XDH |
2.91315 |
[BP] GO:0031635 |
None
|
OPRK1, OPRM1 |
2.91315 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.91315 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APP, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, HCAR2, HSD17B1, HSD17B2, HTR1A, HTR2A, HTR7, IGF1R, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, OPRD1, OPRK1, OPRM1, PDE10A, PDE3A, PDE3B, PIM1, PPARA, PTPN1, SENP6, SIGMAR1, SRC, TYR, XDH |
2.89788 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CYP19A1, DRD1, DRD2, ESR1, FABP4, KDR, MET, MIF, MMP12, OPRM1, PPARA |
2.89414 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AURKB, CYP1A1, ESR1, FLT3, HTR1A, MET, MIF, PIM1, SRC, TYR |
2.89095 |
[BP] GO:2001023 |
None
|
DRD1, DRD2, HTR2A, MET, OPRK1 |
2.8621 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.8621 |
[BP] GO:0006198 |
None
|
PDE10A, PDE3A, PDE3B |
2.8621 |
[BP] GO:0051967 |
None
|
ADORA1, DRD2, HTR2A |
2.8621 |
[BP] GO:0050730 |
None
|
ADORA1, APP, FLT3, HTR2A, MIF, PTPN1, SRC |
2.85907 |
[BP] GO:0006195 |
None
|
PDE10A, PDE3A, PDE3B, XDH |
2.85821 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, HTR2A, SRC |
2.85821 |
[BP] GO:1901699 |
cellular response to nitrogen compound
|
AKR1B1, APP, DRD1, IGF1R, MMP2, OPRM1, PDE3A, PDE3B, SRC |
2.84633 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD2, FABP3, PPARA |
2.82785 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, APP, DRD1, ESR1, FLT3, IGF1R, MMP2, OPRM1, PDE3A, PDE3B, SRC |
2.7441 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADORA1, APP, CDC25B, DRD1, DRD2, FABP4, FLT3, HTR2A, IGF1R, KDR, MIF, MMP9, OPRD1, OPRK1, OPRM1, PTPN1, SRC, XDH |
2.74371 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, APP, AURKB, CSNK2A1, CYP2D6, DRD2, ESR1, ESR2, ESRRA, FABP4, HCAR2, IGF1R, KDR, MET, MIF, MMP12, MMP9, OPRD1, OPRM1, PDE3B, PPARA, PTPN1, SRC, XDH |
2.74248 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADORA1, APP, AXL, CA2, CYP19A1, DRD1, DRD2, HCAR2, MIF, MMP12, OPRK1, SRC |
2.72488 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.70275 |
[BP] GO:0043266 |
None
|
ADORA1, DRD1, DRD2, HTR2A, OPRK1 |
2.69333 |
[BP] GO:0006939 |
None
|
DRD1, DRD2, HTR2A, HTR7 |
2.68741 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, APP, CDC25B, CSNK2A1, DRD2, ESR1, FLT3, HTR2A, KDR, MIF, MMP9, OPRD1, OPRK1, OPRM1, PTPN1, SRC, XDH |
2.67253 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, SRC |
2.67188 |
[BP] GO:1901361 |
None
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP2A6, PDE10A, PDE3A, PDE3B, XDH |
2.66901 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, APP, AURKB, CDC25B, CSNK2A1, CYP1B1, CYP2D6, DRD1, DRD2, ESR1, ESR2, FABP4, FLT3, HTR2A, IGF1R, MET, MIF, MMP9, OPRD1, OPRM1, PIM1, PPARA, PTPN1, SRC, XDH |
2.66772 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, AKR1B1, APP, AURKB, AXL, CSNK2A1, CYP1B1, DRD2, ESR1, ESR2, FLT3, HTR2A, IGF1R, KDR, MET, MIF, MMP12, MMP9, OPRK1, OPRM1, PDE10A, PDE3B, PTPN1, SRC, XDH |
2.65022 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APP, FABP3, IGF1R, OPRK1, PDE3B, PPARA, SRC |
2.64983 |
[BP] GO:0009214 |
None
|
PDE10A, PDE3A, PDE3B |
2.63637 |
[BP] GO:0080134 |
regulation of response to stress
|
ADORA1, APP, CYP19A1, DRD2, ESR1, FABP4, IGF1R, MET, MIF, MMP12, MMP2, OPRK1, PPARA, PTPN1, SRC, XDH |
2.63634 |
[BP] GO:0002793 |
None
|
ACHE, ADORA1, DRD2, HCAR2, MIF, MMP12, SRC |
2.62683 |
[BP] GO:0050731 |
positive regulation of peptidyl-tyrosine phosphorylation
|
ADORA1, FLT3, HTR2A, MIF, PTPN1, SRC |
2.60024 |
[BP] GO:1903532 |
None
|
ACHE, CYP19A1, DRD2, HCAR2, MIF, MMP12, OPRK1, SRC |
2.59744 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, CYP1A1, DRD2, MMP2, OPRD1, PPARA, SRC |
2.58904 |
[BP] GO:0050994 |
None
|
ADORA1, HCAR2, PDE3B, PPARA |
2.5742 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FABP3, MIF, PIM1, PPARA, TYR |
2.56605 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, CYP19A1, DRD1, DRD2, ESR1, ESR2, IGF1R, MET, MIF, MMP12, MMP9, PDE3B, PPARA, PTPN1, SRC, XDH |
2.56428 |
[BP] GO:0046883 |
regulation of hormone secretion
|
ADORA1, CYP19A1, DRD2, HCAR2, HTR1A, HTR2A, OPRK1 |
2.55548 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, CYP1A1, DRD2, OPRM1, PPARA |
2.5331 |
[BP] GO:0007626 |
None
|
APP, DRD1, DRD2, OPRD1, OPRK1, OPRM1 |
2.5331 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, MMP9, SRC |
2.52953 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.52664 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.52664 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, CYP1A1, DRD2, MMP2, OPRD1, PPARA, SRC |
2.5259 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4 |
2.50015 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.45531 |
[BP] GO:0032496 |
response to lipopolysaccharide
|
ALPL, AXL, CYP1A1, CYP1A2, OPRK1, OPRM1, SRC |
2.43467 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2D6 |
2.43453 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADORA1, APP, CDC25B, DRD2, ESR1, FLT3, HTR2A, KDR, MIF, MMP9, OPRD1, OPRK1, OPRM1, PTPN1, SRC, XDH |
2.43453 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.42489 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PTPN1, SRC |
2.40498 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, AXL, CYP1B1, DRD1, KDR, OPRM1, SRC |
2.39567 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
ADORA1, DRD1, DRD2, HTR2A |
2.39567 |
[BP] GO:0003008 |
None
|
ADORA1, AKR1B1, APP, CYP1B1, DRD1, DRD2, HTR1A, HTR2A, HTR7, OPRD1, OPRK1, OPRM1, PDE3A, SRC, TYR |
2.35899 |
[BP] GO:0042698 |
ovulation cycle
|
AXL, OPRK1, OPRM1 |
2.35169 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.35169 |
[BP] GO:0050995 |
None
|
ADORA1, HCAR2, PDE3B |
2.35169 |
[BP] GO:0097237 |
cellular response to toxic substance
|
AKR1B1, AXL, CYP1B1, KDR, OPRD1 |
2.35169 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, CYP1A1, DRD2, MMP2, OPRD1, PPARA, SRC |
2.32705 |
[BP] GO:0007268 |
None
|
DRD1, DRD2, HTR2A, HTR7, OPRD1, OPRK1, OPRM1 |
2.32081 |
[BP] GO:0098916 |
None
|
DRD1, DRD2, HTR2A, HTR7, OPRD1, OPRK1, OPRM1 |
2.32081 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, HTR2A, PPARA, SRC |
2.30686 |
[BP] GO:0009166 |
None
|
PDE10A, PDE3A, PDE3B, XDH |
2.30552 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.30283 |
[BP] GO:0097746 |
None
|
ADORA1, DRD1, HTR1A, HTR2A, HTR7 |
2.2963 |
[BP] GO:0035296 |
None
|
ADORA1, DRD1, HTR1A, HTR2A, HTR7 |
2.2963 |
[BP] GO:0002237 |
response to molecule of bacterial origin
|
ALPL, AXL, CYP1A1, CYP1A2, OPRK1, OPRM1, SRC |
2.29295 |
[BP] GO:0050795 |
None
|
ADORA1, DRD2, HTR1A, HTR2A |
2.28756 |
[BP] GO:0007198 |
None
|
HTR1A, HTR7 |
2.28756 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.28756 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
CA2, CA7 |
2.28756 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.28756 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
ADORA1, APP, CDC25B, DRD2, FABP4, FLT3, HTR2A, IGF1R, MIF, PTPN1, SRC |
2.28445 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, AURKB, AXL, CDC25B, CSNK2A1, DRD1, FLT3, IGF1R, KDR, MET, PIM1, SRC |
2.28186 |
[BP] GO:0099536 |
None
|
DRD1, DRD2, HTR2A, HTR7, OPRD1, OPRK1, OPRM1 |
2.28186 |
[BP] GO:0099537 |
None
|
DRD1, DRD2, HTR2A, HTR7, OPRD1, OPRK1, OPRM1 |
2.28186 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, HSD11B1, HSD17B1, HSD17B2 |
2.28186 |
[BP] GO:0043393 |
regulation of protein binding
|
APP, AURKB, MET, MMP9, PPARA, SRC |
2.28186 |
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.27863 |
[BP] GO:0007210 |
None
|
HTR1A, HTR2A, HTR7 |
2.27863 |
[BP] GO:0098664 |
None
|
HTR1A, HTR2A, HTR7 |
2.27863 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.27863 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, APP, CA12, CA2, CA7, DRD1, DRD2, ESR1, FABP3, FABP4, HTR2A, MET |
2.2629 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, APP, AURKB, CA9, CDC25B, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, HCAR2, HTR1A, HTR2A, IGF1R, KDR, MET, MIF, MMP12, MMP9, OPRD1, OPRK1, OPRM1, PDE3B, PIM1, PPARA, PTPN1, SRC, XDH |
2.2624 |
[BP] GO:0043436 |
oxoacid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FABP3, MIF, PIM1, PPARA, TYR |
2.24826 |
[BP] GO:0030198 |
extracellular matrix organization
|
APP, CYP1B1, KDR, MMP1, MMP12, MMP2, MMP9 |
2.2215 |
[BP] GO:0045913 |
None
|
ESRRB, HTR2A, PPARA, SRC |
2.21946 |
[BP] GO:0043062 |
extracellular structure organization
|
APP, CYP1B1, KDR, MMP1, MMP12, MMP2, MMP9 |
2.21552 |
[BP] GO:0007610 |
None
|
APP, DRD1, DRD2, HTR1A, HTR2A, OPRD1, OPRK1, OPRM1, PPARA |
2.21426 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, AKR1B1, APP, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, HTR1A, MIF, MMP2, MMP9, OPRD1, OPRK1, OPRM1, PPARA, PTPN1, SRC |
2.21263 |
[BP] GO:0050880 |
None
|
ADORA1, DRD1, HTR1A, HTR2A, HTR7 |
2.21263 |
[BP] GO:0090087 |
None
|
ACHE, ADORA1, APP, CA2, DRD2, HCAR2, MIF, MMP12, OPRM1, PTPN1, SRC |
2.20775 |
[BP] GO:1901292 |
None
|
PDE10A, PDE3A, PDE3B, XDH |
2.20296 |
[BP] GO:0035150 |
None
|
ADORA1, DRD1, HTR1A, HTR2A, HTR7 |
2.20126 |
[BP] GO:0006082 |
organic acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FABP3, MIF, PIM1, PPARA, TYR |
2.1903 |
[BP] GO:0007416 |
None
|
ACHE, APP, DRD1, DRD2 |
2.18398 |
[BP] GO:0031644 |
None
|
ADORA1, OPRD1, OPRK1, OPRM1 |
2.18398 |
[BP] GO:0065007 |
biological regulation
|
ACHE, ADORA1, ADORA3, AKR1B1, APP, AURKB, AXL, CA1, CA12, CA2, CA7, CA9, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, HCAR2, HSD11B1, HSD17B1, HSD17B2, HTR1A, HTR2A, HTR7, IGF1R, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, OPRD1, OPRK1, OPRM1, PDE10A, PDE3A, PDE3B, PIM1, PPARA, PTPN1, SENP6, SIGMAR1, SRC, XDH |
2.16944 |
[BP] GO:0048609 |
multicellular organismal reproductive process
|
AKR1B1, APP, AXL, CYP1A1, DRD1, ESR1, OPRK1, OPRM1, SRC |
2.16871 |
[BP] GO:0008306 |
None
|
APP, DRD1, DRD2, OPRK1 |
2.16622 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, CSNK2A1, CYP19A1, CYP1A1, HSD11B1, HSD17B1, HSD17B2, MIF |
2.15501 |
[BP] GO:0010038 |
response to metal ion
|
APP, CA2, CYP1A1, CYP1A2, DRD2, FABP4, MMP9 |
2.15249 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, FLT3, HTR2A, SRC |
2.14956 |
[BP] GO:0032868 |
None
|
FABP3, OPRK1, PDE3B, PPARA, SRC |
2.13062 |
[BP] GO:0044243 |
multicellular organismal catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.13062 |
[BP] GO:0021853 |
None
|
DRD1, DRD2 |
2.13062 |
[BP] GO:1904936 |
None
|
DRD1, DRD2 |
2.13062 |
[BP] GO:0042321 |
None
|
ADORA1, DRD2 |
2.13062 |
[BP] GO:0016477 |
cell migration
|
AXL, CYP1B1, DRD1, DRD2, FUT7, KDR, MIF, MMP1, MMP12, MMP9, SRC |
2.12982 |
[BP] GO:0042755 |
None
|
OPRD1, OPRK1, OPRM1 |
2.1225 |
[BP] GO:0014059 |
None
|
DRD2, HTR2A, OPRK1 |
2.1225 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, DRD1, DRD2, HCAR2 |
2.10917 |
[BP] GO:0019098 |
None
|
APP, DRD1, OPRK1 |
2.08123 |
[BP] GO:0042310 |
None
|
HTR1A, HTR2A, HTR7 |
2.08123 |
[BP] GO:0043549 |
regulation of kinase activity
|
ADORA1, APP, CDC25B, DRD2, FABP4, FLT3, HTR2A, IGF1R, MIF, PTPN1, SRC |
2.07545 |
[BP] GO:0032845 |
None
|
ADORA1, DRD2, HTR2A, MIF, SRC |
2.07545 |
[BP] GO:0009154 |
None
|
PDE10A, PDE3A, PDE3B |
2.04032 |
[BP] GO:0008344 |
None
|
APP, DRD1, DRD2, OPRD1 |
2.03686 |
[BP] GO:1900542 |
None
|
DRD1, DRD2, ESRRB, HTR2A, OPRM1, PPARA |
2.03686 |
[BP] GO:0002791 |
None
|
ACHE, ADORA1, DRD2, HCAR2, MIF, MMP12, OPRM1, SRC |
2.03507 |
[BP] GO:0050714 |
None
|
ACHE, DRD2, HCAR2, MIF, MMP12, SRC |
2.02927 |
[BP] GO:0051338 |
regulation of transferase activity
|
ADORA1, APP, AURKB, CDC25B, DRD2, FABP4, FLT3, HTR2A, IGF1R, MIF, PTPN1, SRC |
2.02702 |
[BP] GO:0022617 |
extracellular matrix disassembly
|
MMP1, MMP12, MMP2, MMP9 |
2.02088 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADORA1, FLT3, HTR2A, IGF1R, MIF, PTPN1, SRC |
2.01319 |
[BP] GO:0009261 |
None
|
PDE10A, PDE3A, PDE3B |
2.00832 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, APP, AXL, CA4, DRD1, DRD2, FLT3, HTR1A, HTR2A, HTR7, IGF1R, KDR, MET, OPRD1, OPRK1, OPRM1, SIGMAR1 |
3.64875 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA1, ADORA3, APP, AXL, DRD1, DRD2, FLT3, HTR1A, HTR2A, HTR7, IGF1R, KDR, MET, OPRD1, OPRK1, OPRM1, SIGMAR1 |
3.31351 |
[CC] GO:0044425 |
membrane part
|
ACHE, ADORA1, ADORA3, ALPL, APP, AXL, CA12, CA14, CA2, CA4, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, DRD2, ESR1, FLT3, FUT7, HCAR2, HSD11B1, HSD17B2, HTR1A, HTR2A, HTR7, IGF1R, KDR, MET, OPRD1, OPRK1, OPRM1, PDE3A, PDE3B, PTPN1, SIGMAR1, SRC, TYR |
3.13736 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA1, ADORA3, ALOX5, ALPL, APP, AXL, CA12, CA14, CA2, CA4, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, DRD2, ESR1, FLT3, FUT7, HCAR2, HSD11B1, HSD17B2, HTR1A, HTR2A, HTR7, IGF1R, KDR, MET, MMP2, OPRD1, OPRK1, OPRM1, PDE10A, PDE3B, PIM1, PTPN1, SIGMAR1, SRC, TYR |
3.12361 |
[CC] GO:0031253 |
None
|
ADORA1, CA4, CA9, DRD1, DRD2, OPRD1, OPRM1, SRC |
2.91296 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA1, ADORA3, ALPL, APP, AXL, CA12, CA14, CA2, CA4, CA9, CSNK2A1, DRD1, DRD2, ESR1, FLT3, HCAR2, HTR1A, HTR2A, HTR7, IGF1R, KDR, MET, MMP2, OPRD1, OPRK1, OPRM1, PIM1, PTPN1, SRC |
2.41079 |
[CC] GO:0044463 |
None
|
ADORA1, AKR1B1, APP, CA4, CA9, DRD1, DRD2, HTR2A, OPRD1, OPRK1, OPRM1, SIGMAR1, SRC |
2.38338 |
[CC] GO:0120038 |
None
|
ADORA1, AKR1B1, APP, CA4, CA9, DRD1, DRD2, HTR2A, OPRD1, OPRK1, OPRM1, SIGMAR1, SRC |
2.38338 |
[CC] GO:0005783 |
None
|
ADORA1, APP, CA4, CYP19A1, CYP2D6, FLT3, KDR, OPRM1, PDE3B, PTPN1, SIGMAR1, XDH |
2.27464 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, FLT3, HSD11B1, HSD17B2, PTPN1, SIGMAR1 |
2.17606 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, AOX1, APP, AURKB, CA1, CA2, CA4, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, DRD2, ESR1, ESR2, FABP3, FABP4, FLT3, FUT7, HSD11B1, HSD17B1, HSD17B2, HTR2A, KDR, MIF, MMP2, MMP9, OPRM1, PDE10A, PDE3A, PDE3B, PIM1, PTPN1, SENP6, SIGMAR1, SRC, TYR, XDH |
2.16622 |
[CC] GO:0098590 |
plasma membrane region
|
ADORA1, CA2, CA4, CA9, DRD1, DRD2, HTR2A, MET, OPRD1, OPRM1, SIGMAR1, SRC |
2.15017 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, AOX1, APP, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, TYR, XDH |
14.4578 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
9.74701 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX5, ALPL, AOX1, APP, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, HSD17B1, HTR1A, HTR2A, HTR7, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PDE10A, PDE3A, PDE3B, PIM1, PPARA, PTPN1, SRC, TYR, XDH |
9.69681 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, ALPL, AOX1, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, HTR1A, HTR2A, HTR7, MMP1, MMP12, MMP2, MMP9, PDE10A, PDE3A, PDE3B, PIM1, PPARA, PTPN1, TYR, XDH |
8.32139 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6 |
8.31453 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FLT3, FUT7, HSD11B1, HSD17B1, HSD17B2, IGF1R, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, PDE10A, PDE3A, PDE3B, PIM1, PTPN1, SENP6, SRC, TYR, XDH |
7.62619 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2D6 |
6.80755 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, XDH |
6.75276 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, AXL, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, FLT3, HCAR2, HTR1A, HTR2A, HTR7, IGF1R, KDR, MET, OPRD1, OPRK1, OPRM1, PPARA, SIGMAR1 |
6.4093 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.23258 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, TYR |
6.03173 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, HSD11B1, HSD17B1, HSD17B2, TYR, XDH |
5.81987 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, AXL, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, FLT3, HCAR2, HTR1A, HTR2A, HTR7, IGF1R, KDR, MET, OPRD1, OPRK1, OPRM1, PPARA, SIGMAR1 |
5.61794 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
5.45255 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, AXL, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, FLT3, HCAR2, HTR1A, HTR2A, HTR7, IGF1R, KDR, MET, OPRD1, OPRK1, OPRM1, PPARA, SIGMAR1 |
5.41959 |
[MF] GO:0004985 |
None
|
OPRD1, OPRK1, OPRM1, SIGMAR1 |
5.38972 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2D6 |
5.36787 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA7, CA9, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, PPARA, PTPN1 |
5.36069 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, SRC |
5.28425 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, ALPL, AOX1, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, PDE10A, PDE3A, PDE3B, PIM1, PPARA, PTPN1, TYR, XDH |
5.23178 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, SRC |
5.10376 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, AXL, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, FLT3, HCAR2, HTR1A, HTR2A, HTR7, IGF1R, KDR, MET, OPRD1, OPRK1, OPRM1, PPARA, SIGMAR1 |
5.06741 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2D6, DRD1, DRD2, FLT3, HTR2A, IGF1R, KDR, MET, PDE10A, PIM1, PPARA, SIGMAR1, SRC |
5.01698 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, TYR |
4.78674 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP2A13, CYP2A6, CYP2D6 |
4.58427 |
[MF] GO:0070405 |
ammonium ion binding
|
ACHE, DRD1, DRD2, HTR1A, HTR2A, HTR7 |
4.38117 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AOX1, HSD11B1, HSD17B1, HSD17B2, XDH |
4.08435 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, HSD17B1, SRC, XDH |
3.90534 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
ESR1, ESR2, ESRRA, ESRRB, PPARA |
3.90292 |
[MF] GO:0004879 |
nuclear receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA |
3.90292 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, AXL, DRD1, DRD2, FLT3, HCAR2, HTR1A, HTR2A, HTR7, IGF1R, KDR, MET, OPRD1, OPRK1, OPRM1, SIGMAR1 |
3.89268 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, AXL, DRD1, DRD2, FLT3, HCAR2, HTR1A, HTR2A, HTR7, IGF1R, KDR, MET, OPRD1, OPRK1, OPRM1, SIGMAR1 |
3.89268 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA |
3.56442 |
[MF] GO:0030594 |
None
|
DRD1, DRD2, HTR1A, HTR2A, HTR7, OPRM1 |
3.52352 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.47662 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
3.35796 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, CSNK2A1, ESRRB, FLT3, HTR2A, IGF1R, KDR, MMP12, MMP9, PIM1, PPARA, PTPN1, SRC |
3.19186 |
[MF] GO:0043176 |
None
|
HTR1A, HTR2A, HTR7 |
3.12738 |
[MF] GO:0051378 |
None
|
HTR1A, HTR2A, HTR7 |
3.12738 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.05991 |
[MF] GO:0099528 |
None
|
HTR1A, HTR2A, HTR7, OPRM1 |
3.01385 |
[MF] GO:0005496 |
steroid binding
|
ESR1, ESR2, ESRRA, ESRRB, HSD17B1 |
2.91315 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.91315 |
[MF] GO:0004119 |
None
|
PDE3A, PDE3B |
2.91315 |
[MF] GO:0008389 |
None
|
CYP2A13, CYP2A6 |
2.91315 |
[MF] GO:0047555 |
None
|
PDE10A, PDE3A, PDE3B |
2.8621 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, ESRRB, FLT3, HTR2A, IGF1R, KDR, MMP12, MMP9, PPARA, PTPN1, SRC |
2.85821 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AOX1, XDH |
2.82386 |
[MF] GO:0004115 |
None
|
PDE10A, PDE3A, PDE3B |
2.78219 |
[MF] GO:0042165 |
neurotransmitter binding
|
ACHE, HTR1A, HTR2A, HTR7 |
2.5742 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, XDH |
2.52953 |
[MF] GO:0004930 |
None
|
ADORA1, ADORA3, DRD1, DRD2, HCAR2, HTR1A, HTR2A, HTR7, OPRD1, OPRK1, OPRM1, SIGMAR1 |
2.52472 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.51814 |
[MF] GO:0008227 |
None
|
DRD2, HTR1A, HTR2A, HTR7 |
2.4417 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, HSD11B1, HSD17B1, HSD17B2 |
2.35945 |
[MF] GO:0042923 |
None
|
OPRD1, OPRK1, OPRM1 |
2.35169 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.28756 |
[MF] GO:0004993 |
None
|
HTR1A, HTR2A, HTR7 |
2.27863 |
[MF] GO:0004114 |
None
|
PDE10A, PDE3A, PDE3B |
2.27863 |
[MF] GO:0099589 |
None
|
HTR1A, HTR2A, HTR7 |
2.27863 |
[MF] GO:0004112 |
None
|
PDE10A, PDE3A, PDE3B |
2.23129 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
HSD11B1, HSD17B1, HSD17B2 |
2.15501 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.13062 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
HSD11B1, HSD17B1, HSD17B2 |
2.08123 |
[MF] GO:0005158 |
None
|
IGF1R, PTPN1, SRC |
2.00832 |